A phase 1 study of crizotinib and ganetespib (STA-9090) in ALK positive lung cancers Meeting Abstract


Authors: Riely, G. J.; Yu, H. A.; Stephens, D.; Pietanza, M. C.; Smith-Marrone, S.; Fiore, J. J.; Goldstein, M.; Sima, C. S.; Kris, M. G.; Ginsberg, M. S.
Abstract Title: A phase 1 study of crizotinib and ganetespib (STA-9090) in ALK positive lung cancers
Meeting Title: 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036901776
PROVIDER: wos
Notes: Meeting Abstract: 8064 -- Source: Wos
MSK Authors
  1. Camelia S Sima
    204 Sima
  2. Michelle S Ginsberg
    158 Ginsberg
  3. Helena Alexandra Yu
    88 Yu
  4. John J Fiore
    7 Fiore
  5. Maria C Pietanza
    115 Pietanza
  6. Gregory J Riely
    344 Riely
  7. Mark Kris
    597 Kris